Elekta (OTCMKTS:EKTAY) Shares Gap Down – Here’s Why

Elekta AB (OTCMKTS:EKTAY)’s share price gapped down before the market opened on Thursday . The stock had previously closed at $5.39, but opened at $5.1150. Elekta shares last traded at $5.1150, with a volume of 753 shares traded.

Wall Street Analyst Weigh In

Separately, Zacks Research raised Elekta from a “strong sell” rating to a “hold” rating in a report on Tuesday, July 28th. One investment analyst has rated the stock with a Hold rating, According to MarketBeat, Elekta presently has a consensus rating of “Hold”.

Elekta Stock Down 2.0%

The firm has a 50 day moving average of $5.26 and a 200-day moving average of $5.65. The company has a debt-to-equity ratio of 0.47, a current ratio of 0.87 and a quick ratio of 0.68. The stock has a market capitalization of $1.85 billion, a P/E ratio of -41.79 and a beta of 1.05.

Elekta (OTCMKTS:EKTAY) last posted its quarterly earnings results on Thursday, August 27th. The company reported $0.07 earnings per share (EPS) for the quarter. Elekta had a negative net margin of 2.38% and a positive return on equity of 13.31%. The firm had revenue of $372.30 million during the quarter. On average, equities research analysts expect that Elekta AB will post 0.43 earnings per share for the current fiscal year.

About Elekta

Elekta is a global medical technology company specializing in the development, manufacture and support of precision radiation therapy and radiosurgery equipment. Its products and services aim to improve patient outcomes in oncology and neurosurgery by combining advanced hardware, software and clinical workflow solutions. Elekta’s offerings are designed to address a broad range of cancer types and brain disorders through targeted, image-guided treatments.

The company’s core product portfolio includes linear accelerators for external beam radiation therapy, stereotactic radiosurgery systems such as the renowned Gamma Knife platform, and brachytherapy solutions for internal radiation treatment.